Eli Lilly’s Ebglyss (lebrikizumab-lbkz) showed improvement in skin clearance and itch relief for most patients with ...

Kebilidi is a one-time gene therapy administered directly to the brain in patients with AADC deficiency, rare genetic ...

Their results argue for a change to parity between small-molecule agents and biologics when it comes to Inflation Reduction ...

In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...